This inventor holds 1 USPTO granted patent and 9 published patent applications. Top assignee: Southern Illinois University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Daniel O’Reilly and Anti-CRISPR Innovation.
Introduction
Daniel O’Reilly is an inventor associated with Barnham, Great Britain. His patent work concerns molecular tools that inhibit CRISPR-Cas effector enzymes, a field relevant to the control and development of gene-editing technologies.
Latest Patents
O’Reilly is listed as an inventor on 1 patent: “Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas Effector Enzymes.” The invention focuses on nucleic acid inhibitors designed to regulate the activity of CRISPR-Cas enzymes.
Career Highlights
The supplied information associates O’Reilly with Southern Illinois University. His listed patent reflects work in biotechnology and the development of approaches for modulating CRISPR-Cas systems.
Collaborations
Masad Damha is identified as O’Reilly’s coworker and is also associated with the patent listed above.
Conclusion
Daniel O’Reilly’s recorded invention centers on anti-CRISPR nucleic acid inhibitors, highlighting his contribution to research on controlling CRISPR-Cas effector enzymes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile